Friday, July 10, 2026

pharma · Female Infertility · Breast Feeding

Abbott Pathology

Abbott Australasia Pty is a pharma organization headquartered in ROME, AU. Primary therapeutic focus areas include Female Infertility, Breast Feeding, Children, Sarcoma, Kaposi, Diabetic Nephropathy. NovaPharmaNews links

Mile End, AU HQ
2001 Founded
41 Employees
TGA registrant Type
Company details
Status
Public
HQ
Mile End, AU
Founded
2001
Employees
41
Programs
6
Drugs
9
Patents
0
Clinical program

ZoMaxx™ Drug-Eluting Coronary Stent System

Phase 3 · other · Coronary Disease

ZoMaxx™ Drug-Eluting Coronary Stent System for Coronary Disease is a Phase 3 program (other) at Abbott Australasia Pty Ltd with 1 ClinicalTrials.gov record(s).

Internal code 640-0047

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Abbott Australasia Pty Ltd
Phase
Phase 3
Modality
other
Indication
Coronary Disease
Status
completed
Trials
1

Clinical trials